Largest biotech companies in the United States by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Amgen leads the 10 biotech companies in the United States ranked by total debt, at PLN 221.6B, ahead of Gilead Sciences (PLN 101.2B) and Biogen (PLN 25.5B). Figures as of 20 Nov 2026, 09:38 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
10
First
AmgenPLN 221.6B
Median
PLN 2.3B
Combined market value
PLN 2.98T
Countries
1
Not ranked
10no total debt on file

Market values as of .

United States
All sectors
Biotech
PLN
Clear filters
Largest biotech companies in the United States by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CarePLN 221.6BPLN 963.5BPLN 1,781.21 1.14% down 32% up United States
2Gilead SciencesGILD · Health CarePLN 101.2BPLN 838.4BPLN 675.96 1.45% down 35% up United States
3BiogenBIIB · Health CarePLN 25.5BPLN 148.3BPLN 1,003.13 1.70% down 49% up United States
4Halozyme TherapeuticsHALO · Health CarePLN 8.7BPLN 43.1BPLN 377.66 2.88% down 39% up United States
5ModernaMRNA · Health CarePLN 2.4BPLN 327.4BPLN 809.10 1.29% up 780% up United States
6RepligenRGEN · Health CarePLN 2.2BPLN 44.2BPLN 691.22 1.38% down 12% up United States
7Bio-TechneTECH · Health CarePLN 811.8MPLN 46.4BPLN 295.10 0.07% down 24% up United States
8Adaptive BiotechnologiesADPT · Health CarePLN 532.6MPLN 18.4BPLN 113.86 1.44% down 74% up United States
9Scholar Rock HoldingSRRK · Health CarePLN 404.7MPLN 24.9BPLN 204.46 4.94% up 26% up United States
10CG OncologyCGON · Health CarePLN 12.2MPLN 29.7BPLN 332.44 2.38% up 97% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0591 PLN). 10 companies have no total debt on file and are not ranked here.

Questions and answers

Which biotech companies in the United States rank first by total debt?

Amgen (PLN 221.6B), Gilead Sciences (PLN 101.2B) and Biogen (PLN 25.5B) are the top three of the 10 biotech companies in the United States ranked by total debt as of 20 Nov 2026, 09:38 UTC.

How many biotech companies in the United States are in this ranking?

10 are ranked by total debt. 10 more have no total debt on file and are left out rather than ranked at zero.

What are these biotech companies in the United States worth together?

The 10 biotech companies in the United States ranked by total debt have a combined market value of PLN 2.98T as of 20 Nov 2026, 09:38 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest biotech companies in the United States by total debt”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.